Major diabetes drug study launches in pakistan
Disease control
Recruiting now
This study aims to monitor the real-world safety and effectiveness of the diabetes medication empagliflozin, taken with or without metformin, in Pakistani adults. It will follow 2000 participants for up to 6 months to track side effects and how well the drug controls blood sugar …
Phase: PHASE4 • Sponsor: Getz Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC